Header cover image

Investing Ideas
/
U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

12

1 new

High return on equity, past performance and sound balance sheet.

12 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	ACAD ACADIA Pharmaceuticals	US$16.21	-7.8%	-26.3%	US$2.7b	US$25.11	PE21x	E28.4%	n/a
	MEDP Medpace Holdings	US$314.96	-13.0%	13.8%	US$9.8b	US$349.32	PE26.7x	E10.9%	n/a
	A Agilent Technologies	US$125.69	-6.4%	1.4%	US$36.1b	US$150.11	PE25.6x	E4.1%	0.8%
	CPRX Catalyst Pharmaceuticals	US$21.39	-6.2%	54.3%	US$2.6b	US$32.25	PE17.9x	E17.5%	n/a
	PTGX Protagonist Therapeutics	US$38.65	-9.4%	129.6%	US$2.3b	US$54.38	PE13.5x	E-31.4%	n/a
	EXEL Exelixis	US$34.41	-2.2%	60.0%	US$9.8b	US$31.83	PE21x	E15.6%	n/a
	ETST Earth Science Tech	US$0.16	27.9%	113.0%	US$48.5m	n/a	PE21.3x	n/a	n/a
	OBSE.F ObsEva	US$0.0001	0%	-99.8%	US$11.7k	n/a	PE0.001x	n/a	n/a
	CORT Corcept Therapeutics	US$54.31	-3.8%	114.3%	US$5.7b	US$74.90	PE40.5x	E41.0%	n/a
	BSEM New BioStem Technologies	US$12.70	-45.6%	323.3%	US$211.1m	US$32.50	PE13.3x	E33.8%	n/a
	PNT POINT Biopharma Global	US$12.50	0.2%	75.1%	US$1.3b	US$12.50	PE13.8x	E9.2%	n/a
	MDXG MiMedx Group	US$9.24	23.7%	22.1%	US$1.4b	US$13.00	PE17.1x	E-1.9%	n/a

Page 1 of 1